Medical Devices: Neurological Devices; Electroconvulsive Therapy Device; Establishing a Public Docket
Document ID: FDA-2009-N-0392-0001
Comments
Total: 1,276
< Prev Page
Page 1
... Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
... Page 42
Page 43
Next Page >
Go To Page:
-
Barry Watson - Comment
Posted : 11/16/2009 ID :FDA-2009-N-0392-0153 Agency : FDA -
Jan 08,2010 11:59 PM ET
-
Pearl Lantz - Comment
Posted : 11/16/2009 ID :FDA-2009-N-0392-0154 Agency : FDA -
Jan 08,2010 11:59 PM ET
-
Katherine Markham - Comment
Posted : 11/16/2009 ID :FDA-2009-N-0392-0155 Agency : FDA -
Jan 08,2010 11:59 PM ET
-
Ingrid Eckhoff - Comment
Posted : 11/16/2009 ID :FDA-2009-N-0392-0156 Agency : FDA -
Jan 08,2010 11:59 PM ET
-
David C. Sanders - Comment
Posted : 11/17/2009 ID :FDA-2009-N-0392-0157 Agency : FDA -
Jan 08,2010 11:59 PM ET
-
Marcia Sue Clever, M.D. - Comment
Posted : 11/17/2009 ID :FDA-2009-N-0392-0158 Agency : FDA -
Jan 08,2010 11:59 PM ET
-
Andrew D. Reisner, Psy.D. - Comment
Posted : 11/17/2009 ID :FDA-2009-N-0392-0159 Agency : FDA -
Jan 08,2010 11:59 PM ET
-
Yvonne B. Ferguson, M.D. - Comment
Posted : 11/17/2009 ID :FDA-2009-N-0392-0160 Agency : FDA -
Jan 08,2010 11:59 PM ET
-
eugene john schneider - Comment
Posted : 11/19/2009 ID :FDA-2009-N-0392-0161 Agency : FDA -
Jan 08,2010 11:59 PM ET
-
Mary Ellen Maddock - Comment
Posted : 11/20/2009 ID :FDA-2009-N-0392-0162 Agency : FDA -
Jan 08,2010 11:59 PM ET
-
Nicholas Mauser - Comment
Posted : 11/23/2009 ID :FDA-2009-N-0392-0163 Agency : FDA -
Jan 08,2010 11:59 PM ET
-
Mark S Bauer - Comment
Posted : 11/24/2009 ID :FDA-2009-N-0392-0164 Agency : FDA -
Jan 08,2010 11:59 PM ET
-
Robert E. Emerick, Ph.D. - Comment
Posted : 11/24/2009 ID :FDA-2009-N-0392-0165 Agency : FDA -
Jan 08,2010 11:59 PM ET
-
Timothy A. Murphy, M.D. - Comment
Posted : 11/24/2009 ID :FDA-2009-N-0392-0166 Agency : FDA -
Jan 08,2010 11:59 PM ET
-
Alessandro Barchiesi, M.D. - Comment
Posted : 11/24/2009 ID :FDA-2009-N-0392-0167 Agency : FDA -
Jan 08,2010 11:59 PM ET
-
Joshua D. Feder, M.D. - Comment
Posted : 11/24/2009 ID :FDA-2009-N-0392-0168 Agency : FDA -
Jan 08,2010 11:59 PM ET
-
Brian A. Falls - Comment
Posted : 11/30/2009 ID :FDA-2009-N-0392-0169 Agency : FDA -
Jan 08,2010 11:59 PM ET
-
Anonymous - Comment
Posted : 11/30/2009 ID :FDA-2009-N-0392-0170 Agency : FDA -
Jan 08,2010 11:59 PM ET
-
Barry Kramer - Comment
Posted : 12/02/2009 ID :FDA-2009-N-0392-0171 Agency : FDA -
Jan 08,2010 11:59 PM ET
-
Omayra Nieves, M.D. - Comment
Posted : 12/02/2009 ID :FDA-2009-N-0392-0172 Agency : FDA -
Jan 08,2010 11:59 PM ET
-
Wilton Earle Hall III - Comment
Posted : 12/03/2009 ID :FDA-2009-N-0392-0173 Agency : FDA -
Jan 08,2010 11:59 PM ET
-
Worrawat Chanpattana - Comment
Posted : 12/03/2009 ID :FDA-2009-N-0392-0174 Agency : FDA -
Jan 08,2010 11:59 PM ET
-
Charles Rodican - Comment
Posted : 12/04/2009 ID :FDA-2009-N-0392-0175 Agency : FDA -
Jan 08,2010 11:59 PM ET
-
University Medical Group - Comment
Posted : 12/04/2009 ID :FDA-2009-N-0392-0176 Agency : FDA -
Jan 08,2010 11:59 PM ET
-
Scripps Behavioral Health Center - Comment
Posted : 12/04/2009 ID :FDA-2009-N-0392-0177 Agency : FDA -
Jan 08,2010 11:59 PM ET
-
The University of Alabama at Birmingham - Comment
Posted : 12/04/2009 ID :FDA-2009-N-0392-0178 Agency : FDA -
Jan 08,2010 11:59 PM ET
-
State of Delaware Governor's Advisory Council for Exceptional Citizens - Comment
Posted : 12/04/2009 ID :FDA-2009-N-0392-0179 Agency : FDA -
Jan 08,2010 11:59 PM ET
-
Tim Stoner - Comment
Posted : 12/09/2009 ID :FDA-2009-N-0392-0180 Agency : FDA -
Jan 08,2010 11:59 PM ET
-
Peter R. Breggin, MD - Comment
Posted : 12/09/2009 ID :FDA-2009-N-0392-0181 Agency : FDA -
Jan 08,2010 11:59 PM ET
-
Harriet Cohen - Comment
Posted : 12/09/2009 ID :FDA-2009-N-0392-0182 Agency : FDA -
Jan 08,2010 11:59 PM ET
< Prev Page
Page 1
... Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
... Page 42
Page 43
Next Page >
Go To Page: